SignPath Pharma, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/16 Q2

ended 03/31/16 Q1

ended 12/31/15 FY 2015

Late annual filing notification for FY 2015

ended 09/30/15 Q3

Prospectuses and Registrations Filter

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Suspension of duty to report

Exempt offering of securities

Ownership

No filings in this category.

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Change in Certifying Accountant

Change in Certifying Accountant, Financial Statements or Exhibits

Announces IND Approval of Liposomal Curcumin for Clinical Trials of Drug Resistant Non-Small Cell Lung Cancer and Progressive Parkinson’s Disease

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC